22 It has been reported that the V179D/E mutation site for the HIV‐1‐infected MSM CRF01_AE subtype has an increasing trend. 23 It is noteworthy that this study showed that greater than one‐third (36.36% [16/44]) of the overall HIV‐1‐infected MSM drug resistance mutation sites (V179D/E) exhibit potential low‐level resistance to NNTRIs, which may lead to antiviral treatment failure in patients and requires further research.
← all excerpts
Analysis of genotype resistance and HIV-1 transmission risk in HIV-1-infected men who have sex with men in Guiyang, China.
1
—
—